510(k) Report

510(k) · Cleared

Cleared

EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System

K212624510(k) TraditionalCleared Apr 4, 2022229-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ever Fortune.Ai, Co., Ltd. · QIH Automated Radiological Image Processing Software

Cleared on Apr 4, 2022 as substantially equivalent to K203256 (Imbio, LLC, 2021) after a 229-day review. Its family tree reaches back 8 generations to 1995. 3 later devices descend from it.

Decided
Apr 4, 2022
Review
229 days
Class
Class II
Product code
QIH
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to K945512 (1995). 17 ancestors in all, the oldest K945428 (1995). 3 later devices descend from it, 2 citing it directly.

  1. Root · 8 generations backK945512 HRSW Option for CT Twin FlashElscint, Inc. · 1995
  2. 7 generations backK970980 Cardiac Scoring for CT ScannersElscint, Inc. · 1997
  3. 6 generations backK982004 CT Coronary Artery Calcification Scoring (Cacs) Option for Advantage…General Electric Co. · 1998
  4. 5 generations backK020929 Smartscore 3.5; Smartscore 4.0; Smartscore 4.5GE Medical Systems · 2002
  5. 4 generations backK072737 CSCS-001A Calcium Scoring PackageToshiba America Medical Systems, In.C · 2007
  6. 3 generations backK083446 Cardiac Function Analysis, Calcium ScoringZiosoft, Inc. · 2009
  7. 2 generations backK111373 CT42 Cardiac Computed Tomography (CT) SoftwareCircle Cardiovascular Imaging, Inc. · 2011
  8. 1 generation backK203256 Imbio RV/LV SoftwareImbio, LLC · 2021
  9. This deviceK212624 EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment SystemEver Fortune.Ai, Co., Ltd. · 2022
  10. Descendant · cites it directly · 1 of its ownK232613 CT CardiomegalyInnolitics, LLC · 2024
  11. Descendant · 2 generations on · 0 of its ownK243859 PRAEVAorta®2Nurea · 2025
  12. Descendant · cites it directly · 0 of its ownK231149 qXR-CTRQure.Ai Technologies · 2023

Most influential descendants

Showing 3 of 3 · See all
  • K232613CT CardiomegalyInnolitics, LLC · 2024 · cites it directly1descendant
  • K243859PRAEVAorta®2Nurea · 2025 · 2 generations on0descendants
  • K231149qXR-CTRQure.Ai Technologies · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K945512HRSW Option for CT Twin FlashElscint, Inc.1995—
−7K970980Cardiac Scoring for CT ScannersElscint, Inc.1997—
−6K982004CT Coronary Artery Calcification Scoring (Cacs) Option for Advantage WindowsGeneral Electric Co.1998—
−5K020929Smartscore 3.5; Smartscore 4.0; Smartscore 4.5GE Medical Systems2002—
−4K072737CSCS-001A Calcium Scoring PackageToshiba America Medical Systems, In.C2007—
−3K083446Cardiac Function Analysis, Calcium ScoringZiosoft, Inc.2009—
−2K111373CT42 Cardiac Computed Tomography (CT) SoftwareCircle Cardiovascular Imaging, Inc.2011—
−1K203256Imbio RV/LV SoftwareImbio, LLC2021—
0 (this device)K212624EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment SystemEver Fortune.Ai, Co., Ltd.2022—
+1K232613CT CardiomegalyInnolitics, LLC2024—
+2K243859PRAEVAorta®2Nurea2025—
+1K231149qXR-CTRQure.Ai Technologies2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
199610
199710
199910
200020
200110
200220

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
202410
202510
FIG. 1 — Lineage of K212624, 1995–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QIH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QIH device

  1. #1 K213998 cvi42 Auto Imaging Software Applicationscore 23.6 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K203256Imbio RV/LV Software
Summary page 5
…Manufacturer 510(K)# Imbio RV/LV Software Imbio, LLC K203256 The EFAI iCTR is equivalent to the Imbio RV/LV Software (K203256), manufactured by Imbio, LLC is provided as primary predicate…
Imbio, LLC2021—

Also cleared against K203256: 5 other devices →

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K232613CT CardiomegalyInnolitics, LLC20241
K231149qXR-CTRQure.Ai Technologies20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 8 companies; a new generation was cleared every 2.4 years on median.
  • None of the 17 ancestors has a recall.
  • Of its descendants, K232613 (Innolitics, LLC, 2024) has gone furthest, with 1 descendant of its own.
  • 5 other devices also cite its predicate K203256.

How does its category compare?

All QIH devices

QIH Automated Radiological Image Processing Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · QIH

94in 2025

2019: 22020: 112021: 192022: 252023: 452024: 642025: 942026 (partial year): 78
2007high 94 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QIH

150in 2025

2020: 145 days median2021: 125 days median2022: 134 days median2023: 151 days median2024: 141 days median2025: 150 days median2026 (partial year): 130 days median
2007high 151 (2023) · low 125 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QIH

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QIH

4in 2025

2024: 22025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code QIH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20192—00
20201114500
20211912500
20222513400
20234515100
20246414102
20259415004
2026781301—

What is it indicated for?

EFAI Intelligent Cardiothoracic Ratio Assessment System (or iCTR) is a software for use by hospital and clinics to automatically assess the cardiothoracic ratio (CTR) of a chest X-ray image from the X-ray imager subject. The iCTR is designed to measure the maximal transverse diameter of heart and maximal inner transverse diameter of thoracic cavity and calculate the CTR of a chest X-ray image in posterior-anterior (PA) chest view using an artificial…

Read the full statement (142 words)

EFAI Intelligent Cardiothoracic Ratio Assessment System (or iCTR) is a software for use by hospital and clinics to automatically assess the cardiothoracic ratio (CTR) of a chest X-ray image from the X-ray imager subject.

The iCTR is designed to measure the maximal transverse diameter of heart and maximal inner transverse diameter of thoracic cavity and calculate the CTR of a chest X-ray image in posterior-anterior (PA) chest view using an artificial intelligence algorithm.

Intended users of the software are aimed to the physicians or other licensed practitioners in the healthcare institutions, such as clinics, hospitals, healthcare facilities, residential care facilities and long-term care services.

The system is suitable for adults between 20 - 80 years of age.

Its results are not intended to be used on a stand-alone basis for clinical-decision making or otherwise preclude clinical assessment of cardiothoracic ratio (CTR) cases.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K212624: EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K212624

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026